Frexalimab

Tax included
Frexalimab (SAR441344; INX-021) is a monoclonal antibody targeting the CD40 ligand (CD40L). Frexalimab has the potential for multiple sclerosis research.
MedChemExpress 
HY-P99625

Data sheet

Size
Multiple sizes
Reactivity
TNF Receptor
Application
COVID-19-immunoregulation
CAS
2515463-86-0